Felix Sellberg

Uppsala, C 75185, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

A new principle to attenuate ischemia-reperfusion injury in kidney transplantation.

A new principle to attenuate ischemia-reperfusion injury in kidney transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 17, 2025

Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.

Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 09, 2023

Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma.

Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma.

Journal: International journal of molecular sciences

Published: December 19, 2022

Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment.

Serum Proteomics in Patients with Head and Neck Cancer: Peripheral Blood Immune Response to Treatment.

Journal: International journal of molecular sciences

Published: May 07, 2022

Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.

Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity.

Journal: Frontiers in immunology

Published: August 27, 2020

Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent.

Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent.

Journal: Frontiers in oncology

Published: August 24, 2020

Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro.

Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro.

Journal: Frontiers in immunology

Published: August 07, 2020

CD2 Immunobiology.

CD2 Immunobiology.

Journal: Frontiers in immunology

Published: February 06, 2020

Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis.

Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis.

Journal: PloS one

Published: August 19, 2019

Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody.

Pharmacokinetic and pharmacodynamic study of a clinically effective anti-CD2 monoclonal antibody.

Journal: Scandinavian journal of immunology

Published: August 08, 2019

Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study.

Systemic Inflammatory Reaction in Patients With Head and Neck Cancer-An Explorative Study.

Journal: Frontiers in oncology

Published: August 04, 2019

Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro.

Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro.

Journal: Anticancer research

Published: April 10, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026